FDA Outreach To Physicians On LABAs Shows Challenges Of Safety Strategy

FDA appears to have settled on a mechanism for explaining its policy decisions to the physician community: publishing articles in The New England Journal of Medicine. Whether the strategy can produce the desired results remains less clear